Balloon-Occluded Trans-Arterial Chemo-Embolization Technique with Repeated Alternate Infusion of Cisplatin Solution and Sparse Gelatin Slurry (RAIB-TACE) for Large Hepatocellular Carcinoma Nodules More than 7 cm in Diameter.
Aged
Aged, 80 and over
Balloon Occlusion
/ methods
Carcinoma, Hepatocellular
/ diagnostic imaging
Chemoembolization, Therapeutic
/ methods
Cisplatin
/ administration & dosage
Female
Gelatin
/ administration & dosage
Hepatic Artery
Humans
Liver
/ diagnostic imaging
Liver Neoplasms
/ diagnostic imaging
Magnetic Resonance Imaging
Male
Middle Aged
Retrospective Studies
Vascular Surgical Procedures
/ instrumentation
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
08
2019
accepted:
19
12
2019
entrez:
14
2
2020
pubmed:
14
2
2020
medline:
3
11
2020
Statut:
epublish
Résumé
It is sometimes difficult to obtain complete/partial response of large hepatocellular carcinoma (HCC) nodules by trans-arterial chemoembolization/embolization (TACE/TAE). The aim is retrospective investigation of tumor response of large HCC nodules (>7 cm) treated by the new TACE technique, repeated alternate infusion of cisplatin solution, and sparse gelatin slurry under balloon occlusion (RAIB-TACE). CR, PR, SD, and PD were achieved in 11, 8, 0, and 0 nodules, respectively. CR and PR were considered as success, and the ratio of success was 100%. Major complications were abscess formation in the necrotic nodule ( New TACE technique, RAIB-TACE, was useful to achieve successful response of large HCC nodules.
Identifiants
pubmed: 32051830
doi: 10.1155/2020/9289321
pmc: PMC6995320
doi:
Substances chimiques
Gelatin
9000-70-8
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9289321Informations de copyright
Copyright © 2020 Toshiyuki Irie et al.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Cardiovasc Intervent Radiol. 2007 May-Jun;30(3):508-11
pubmed: 17242878
Cardiovasc Intervent Radiol. 2013 Jun;36(3):706-13
pubmed: 22996589
Eur Radiol. 2016 Jun;26(6):1640-8
pubmed: 26455721
Semin Liver Dis. 1999;19(3):329-38
pubmed: 10518312
Oncology. 2014;87 Suppl 1:22-31
pubmed: 25427730
Hepatol Res. 2016 Mar;46(3):E100-4
pubmed: 25988271
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Dig Dis. 2015 Oct;33(6):751-8
pubmed: 26488473
Biomed Res Int. 2019 May 9;2019:8350926
pubmed: 31211142
Radiology. 2005 Oct;237(1):361-5
pubmed: 16118153
Jpn J Radiol. 2015 Dec;33(12):741-8
pubmed: 26493810
Hepatology. 2000 Feb;31(2):269-79
pubmed: 10655246
Gastroenterology. 2006 Aug;131(2):461-9
pubmed: 16890600
Med Oncol. 2015 Mar;32(3):64
pubmed: 25682389
AJR Am J Roentgenol. 2013 Jun;200(6):1370-7
pubmed: 23701078
Cardiovasc Intervent Radiol. 2012 Oct;35(5):980-5
pubmed: 22009576
Clin Cancer Res. 2013 Mar 15;19(6):1312-4
pubmed: 23382112
Hepatol Res. 2016 Feb;46(2):209-14
pubmed: 26224032
Cancer Sci. 2008 Oct;99(10):2104-5
pubmed: 19016772
Radiology. 1983 May;147(2):357-64
pubmed: 6836115
World J Gastroenterol. 2009 Apr 21;15(15):1843-8
pubmed: 19370781
Jpn J Radiol. 2014 May;32(5):260-5
pubmed: 24615165
Jpn J Radiol. 2015 Dec;33(12):790-4
pubmed: 26390870
J Vasc Interv Radiol. 2007 Mar;18(3):365-76
pubmed: 17377182
Eur Radiol. 2011 Aug;21(8):1719-26
pubmed: 21479978